Ligand profile
ZINC32189977
Virtual-screening candidate from ZINC.
Bound to: KP13_03252 — putative transporter protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC32189977- UniProt (similar protein)
Q9KNE0- Tanimoto
- 0.632
- Target protein
- KP13_03252
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 94.8
- −1 ≤ LogP ≤ 5 2.16
- MW ≤ 500 Da 272.3
- LogP ≤ 5 2.16
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 94.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(O)c1ccc(C(O)c2ccc(C(=O)O)cc2)cc1O=C(O)c1ccc(C(O)c2ccc(C(=O)O)cc2)cc1
InChI=1S/C15H12O5/c16-13(9-1-5-11(6-2-9)14(17)18)10-3-7-12(8-4-10)15(19)20/h1-8,13,16H,(H,17,18)(H,19,20)InChI=1S/C15H12O5/c16-13(9-1-5-11(6-2-9)14(17)18)10-3-7-12(8-4-10)15(19)20/h1-8,13,16H,(H,17,18)(H,19,20)
NMAYQOHIMPTMGC-UHFFFAOYSA-NNMAYQOHIMPTMGC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- UB7
- Homolog
- Q9KNE0
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC32189977 →
- ZINC ZINC20 ZINC32189977 →
- UniProt UniProt Q9KNE0 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC32189977”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03252.
PDB 6
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).